AbbVieMEX:ABBV +2.31%72 OCF Yield % is 4.74 as of Jun. 29, 2026, which is 43% below its 10-year median of 8.32. GuruFocus rates MEX:ABBV with a GF Score™ of 72/100 and a GF Value™ of MXN3,624.05 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 1,002 Drug Manufacturers companies, AbbVie ranks better than 57.58% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
AbbVie OCF Yield % Related Terms
AbbVie OCF Yield % Historical Data
* Premium members only.
The historical data trend for AbbVie's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:ABBV vs MRK, JNJ, AMGN: OCF Yield % Comparison
For the Drug Manufacturers - General subindustry, AbbVie's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AbbVie OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AbbVie's OCF Yield % distribution charts can be found below:
* The bar in red indicates where AbbVie's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AbbVie (MEX:ABBV) has a OCF Yield % of 4.74 as of Jun. 29, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on AbbVie and its competitors. This is 43% below median its historical median of 8.32. Over the past decade, AbbVie's OCF Yield % has ranged from 4.58 to 14.03. According to the industry distribution chart, AbbVie ranks #425 out of 1002 companies in the Drug Manufacturers industry, placing it in the top 42.4%.
Is AbbVie's OCF Yield % too high?
AbbVie's current OCF Yield % of 4.74 is 43% below median its 10-year median of 8.32. Over the past 10 years, this metric has ranged from a low of 4.58 to a high of 14.03. The Drug Manufacturers industry median OCF Yield % is 3.61. AbbVie's value of 4.74 is 31.3% above this industry median. Based on the distribution chart, AbbVie ranks #425 out of 1002 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, AbbVie has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AbbVie's OCF Yield % compare to MRK and JNJ?
According to the Drug Manufacturers industry distribution chart, AbbVie ranks #425 out of 1002 companies for OCF Yield %. This puts AbbVie in the upper half of its industry. The industry median OCF Yield % is 3.61. AbbVie's value of 4.74 is 31.3% above this benchmark. Historically, AbbVie's own OCF Yield % has ranged from 4.58 to 14.03 over the past decade. While the company's 10-year median is 8.32 vs. the industry median of 3.61, AbbVie has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.61, based on 1,002 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AbbVie's current OCF Yield % of 4.74 is 31.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on AbbVie and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AbbVie's current OCF Yield % is 4.74, which is 43% below median its own 10-year median of 8.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AbbVie stock overvalued right now?
Based on GuruFocus' analysis, AbbVie (MEX:ABBV) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN3,624.05, compared to a current price of MXN4,343.00 — trading 19.8% above its estimated fair value. The current OCF Yield % is 4.74, which is 43% below median its 10-year median of 8.32 and 31.3% above the Drug Manufacturers industry median of 3.61. AbbVie's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For AbbVie (MEX:ABBV), the current OCF Yield % is 4.74 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AbbVie (MEX:ABBV) Overvalued in 2026?
Based on GuruFocus' analysis, AbbVie stock appears to be overvalued.
The current stock price of MXN4,343.00 is trading 19.8% above its estimated GF Value™ of MXN3,624.05.
GuruFocus considers AbbVie to be Modestly Overvalued.
Key valuation signals for MEX:ABBV:
OCF Yield %: 4.74 (43% below median its 10-year median of 8.32)
GF Value™: MXN3,624.05 vs. price of MXN4,343.00 (19.8% above fair value)
Industry Position: 31.3% above the Drug Manufacturers median (#425 of 1002)
No single metric tells the full story. See the MEX:ABBV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
72GF Score
Get the complete analysis for MEX:ABBV
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ABBV has been successfully added to your 
